Ocular disposition of novel lipophilic diester prodrugs of ganciclovir following intravitreal administration using microdialysis

References

• Holland GN, Pepose JS, Pettit TH, Gottlieb MS, Yee RD, Foos RY. Acquired immune deficiency syndrome. Ocular manifestations. Ophthalmology.1983;90:859–873.
   PubMed Web of Science ®Google Scholar
• Gross JG, Bozzette SA, Mathews WC, Spector SA, Abramson IS, McCutchan JA, Mendez T, Munguia D, Freeman WR. Longitudinal study of cytomegalovirus retinitis in acquired immune deficiency syndrome. Oph-thalmology.1990;97:681–686.
   Google Scholar
• Freeman WR, Lerner CW, Mines JA, Lash RS, Nadel AJ, Starr MB, Tapper ML. A prospective study of the ophthal-mologic findings in the acquired immune deficiency syn-drome. Am J Ophthalmol.1984;97:133–142.
   Google Scholar
• de Jong MD, Galasso GJ, Gazzard B, Griffiths PD, Jabs DA, Kern ER, Spector SA. Summary of the II International Symposium on Cytomegalovirus. Antiviral Res.1998; 39:141–162.
   Google Scholar
• Ng P, McCluskey P, McCaughan G, Glanville A, MacDonald P, Keogh A. Ocular complications of heart, lung, and liver transplantation. Br J Ophthalmol.1998;82: 423–428.
   PubMed Web of Science ®Google Scholar
• Smee DF, Martin JC, Verheyden JP, Matthews TR. Anti-herpesvirus activity of the acyclic nucleoside 941,3-dihydroxy-2-propoxymethyl)guanine. Antimicrob Agents Chemother.1983;23:676–682.
   PubMed Web of Science ®Google Scholar
• Andrei G, Snoeck R, Schots D, Goubau P, Desmyter J, De Clercq E. Comparative activity of selected antiviral com-pounds against clinical isolates of human cytomegalovirus. Eur J Clin Microbiol Infect Dis.1991;10:1026–1033.
   Google Scholar
• Shigeta S, Konno K, Baba M, Yokota T, De Clercq E. Com-parative inhibitory effects of nucleoside analogues on dif-ferent clinical isolates of human cytomegalovirus in vitro. J Infect Dis.1991;163:270–275.
   Google Scholar
• Snoeck R, Schols D, Andrei G, Neyts J, De Clercq E. Antiviral activity of anti-cytomegalovirus agents (HPIVIPC, HIPMPA) assessed by a flow cytometric method and DNA hybridization technique. Antiviral Res.1991;16:1–9.
   Google Scholar
• Konno K, Yokota T, Baba M. Susceptibility of HCMV clinical isolates to ganciclovir and HPMPC. Antivir Res.1993;20(Suppl 1):111.
   Google Scholar
• Manion DJ, Vibhagool A, Chou TC, Kaplan J, Caliendo A, Hirsch MS. Susceptibility of human cytomegalovirus to two-drug combinations in vitro. Antivir Ther.1996;1:237–245.
   PubMedGoogle Scholar
• Markham A, Faulds D. Ganciclovir. An update of its therapeutic use in cytomegalovirus infection. Drugs.1994;48:455–484.
   Google Scholar
• Drew WL. Cytomegalovirus infection in patients with AIDS. J Infect Dis.1988;158:449–456.
   PubMed Web of Science ®Google Scholar
• Faulds D, Heel RC. Ganciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic effi-cacy in cytomegalovirus infections. Drugs.1990;39:597–638.
   Google Scholar
• Martin DF, Sierra-Madero J, Walmsley S, Wolitz RA, Macey K, Georgiou P, Robinson CA, Stempien MJ. A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis. N Engl J Med.2002;346:1119–1126.
   PubMed Web of Science ®Google Scholar
• Henry K, Cantrill H, Fletcher C, Chinnock BJ, Balfour HUI, Jr. Use of intravitreal ganciclovir (dihydroxy propoxymethyl guanine) for cytomegalovirus retinitis in a patient with AIDS. Am J Ophthalmol.1987;103:17–23.
   PubMed Web of Science ®Google Scholar
• Daikos GL, Pulido J, Kathpalia SB, Jackson GG. Intra-venous and intraocular ganciclovir for CMV retinitis in patients with AIDS or chemotherapeutic immunosuppres-sion. Br J Ophthalmol.1988;72:521–524.
   PubMedGoogle Scholar
• Ussery FM, 3rd, Gibson SR, Conklin RH, Piot DF, Stool EW, Conklin AJ. Intravitreal ganciclovir in the treatment of AIDS-associated cytomegalovirus retinitis. Ophthalmol-ogy.1988;95:640–648.
   PubMed Web of Science ®Google Scholar
• Cantrill HL, Henry K, Melroe NH, Knobloch WH, Ramsay RC, Balfour HH, Jr. Treatment of cytomegalovirus retinitis with intravitreal ganciclovir. Long-term results. Ophthal-mology.1989;96:367–374.
   Google Scholar
• Cochereau-Massin I, Lehoang P, Lautier-Frau M, Zazoun L, Marcel P, Robinet M, Matheron S, Katlama C, Gharakhanian S, Rozenbaum W et al.Efficacy and toler-ance of intravitreal ganciclovir in cytomegalovirus retinitis in acquired immune deficiency syndrome. Ophthalmology.1991;98:1348-1353; discussion 1353–1345.
   Google Scholar
• Sakurai E, Matsuda Y, Ozeki H, Kunou N, Nakajima K, Ogura Y. Scleral plug of biodegradable polymers contain-ing ganciclovir for experimental cytomegalovirus retinitis. Invest Ophthalmol Vis Sci.2001;42:2043–2048.
   PubMed Web of Science ®Google Scholar
• Macha S, Mitra AK. Ocular disposition of ganciclovir and its monoester prodrugs following intravitreal administra-tion using microdialysis. Drug Metab Dispos.2002;30: 670–675.
   PubMed Web of Science ®Google Scholar
• Robinson JE. Microdialysis: A novel tool for research in the reproductive system. Biol Reprod.1995;52:237–245.
   PubMed Web of Science ®Google Scholar
• Maggs DG, Borg WP, Sherwin RS. Microdialysis tech-niques in the study of brain and skeletal muscle. Dia-betologia.1997;40(Suppl 2):575–582.
   Google Scholar
• Telting-Diaz M, Scott DO, Lunte CE. Intravenous micro-dialysis sampling in awake, freely-moving rats. Anal Chem.1992;64:806–810.
   Google Scholar
• Stempels N, Tassignon MJ, Sarre S. A removable ocular microdialysis system for measuring vitreous biogenic amines. Graefes Arch Clin Exp Ophthalmol.1993 ;231 : 651–655.
   Google Scholar
• Waga J, Ehinger B. Intravitreal concentrations of some drugs administered with microdialysis. Acta Ophthalmol Scand.1997;75:36–40.
   Google Scholar
• Sato H, Fukuda S, Inatomi M, Koide R, Uchida N, Kanda Y, Kiuchi Y, Oguchi K. [Pharmacokinetics of norfloxacin and lomefloxacin in aqueous humour analysed by micro-dialysis]. Nippon Ganka Gakkai Zasshi.1996;100:513–519.
   PubMedGoogle Scholar
• Hughes PM, Krishnamoorthy R, Mitra AK. Vitreous dis-position of two acycloguanosine antivirals in the albino and pigmented rabbit models: A novel ocular micro-dialysis technique. J Ocul Pharmacol Ther.1996;12:209–224.
   Google Scholar
• Macha S, Mitra AK. Ocular pharmacokinetics in rabbits using a novel dual probe microdialysis technique. Exp Eye Res.2001;72:289–299.
   PubMed Web of Science ®Google Scholar
• Gao H, Mitra AK. Regioselective synthesis of various prodrugs of ganciclovir. Tetrahedron.2000;41 :1131–1136.
   Google Scholar
• Dias CS, Anand BS, Mitra AK. Effect of mono- and di-acylation on the ocular disposition of ganciclovir: Physico-chemical properties, ocular bioreversion, and antiviral activity of short chain ester prodrugs. J Pharm Sci.2002;91:660–668.
   Google Scholar
• Kuppermann BD, Quiceno JI, Flores-Aguilar M, Connor JD, Capparelli EV, Sherwood CH, Freeman WR. Intravit-real ganciclovir concentration after intravenous administra-tion in AIDS patients with cytomegalovirus retinitis: Implications for therapy. J Infect Dis.1993;168:1506–1509.
   Google Scholar
• Lee VH, Chang SC, Oshiro CM, Smith RE. Ocular esterase composition in albino and pigmented rabbits: Possible implications in ocular prodrug design and evaluation. Curr Eye Res.1985;4:1117–1125.
   PubMed Web of Science ®Google Scholar
• Macha S, Mitra AK. Ocular pharmacokinetics of cephalosporins using microdialysis. J Ocul Pharmacol Ther.2001;17:485–498.
   PubMed Web of Science ®Google Scholar
• Lopez-Cortes LF, Pastor-Ramos MT, Ruiz-Valderas R, Cordero E, Uceda-Montanes A, Claro-Cala CM, Lucero-Munoz MJ. Intravitreal pharmacokinetics and retinal con-centrations of ganciclovir and foscarnet after intravitreal administration in rabbits. Invest Ophthalmol Vis Sci.2001; 42:1024–1028.
   PubMed Web of Science ®Google Scholar